Last reviewed · How we verify
NCT04980898: ELEXICA
Electrostimulation System WoundEL for Leg Ulcers Healing (
NA trial testing WoundEL medical device in Leg Ulcer in 22 participants. Terminated before completion.
17 November 2023
Quick facts
| Lead sponsor | CEN Biotech |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 22 |
| Start date | 16 March 2021 |
| Primary completion | 17 November 2023 |
| Estimated completion | 17 November 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- WoundEL medical device
- Standard cares
Conditions studied
- Leg Ulcer — all drugs for Leg Ulcer →
- Electrical Remodeling — all drugs for Electrical Remodeling →
Sponsor
CEN Biotech — full company profile →
Who can join
18 and older, any sex, with Leg Ulcer or Electrical Remodeling. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Several studies have suggested that the endogenous electric field and its polarity stimulate the proliferation and migration of epithelial cells and therefore promote wound healing. WoundEL® will reproduce the endogenous electrical current to stimulate all the factors contributing to healing. Electrostimulation of wounds, including the WoundEL® device, is a therapy listed but not yet reimbursed in France. The aim of this study is to show that the WoundEL® electrostimulation device is superior to the reference treatments recognized by the HAS.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04980898
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Leg Ulcer
Currently open trials in the same condition.
- NCT06153589 — Effectiveness of Musicotherapy in Reducing Pain Induced by Leg Ulcer Care · NA · recruiting
- NCT06674980 — Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DF · NA · recruiting
- NCT05303805 — Topical Sevoflurane for Treatment of Chronic Leg Ulcers · Phase 4 · recruiting
Other CEN Biotech trials
Trials by the same sponsor.
- NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
- NCT07295678 — URGO FilmoCream Eczema + Dermocorticoids in Atopic Dermatitis · NA · not yet recruiting
- NCT06617975 — Knee Osteoarthritis and Spa Therapy · NA · recruiting
- NCT06278324 — Effectiveness of a Nasal Spray on Viral Respiratory Infections · NA · completed
- NCT06054737 — Chronic Venous Insufficiency and Balneotherapy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04980898 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CEN Biotech
- Last refreshed: 6 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04980898.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing